Five-year relative survival rate of uterus cancer in the USA, Europe and Japan.doi:10.1093/jjco/hyu055KumikoSaikaRyokoMachiiJapanese journal of clinical oncology
Epithelial ovarian cancer (EOC) is one of the most aggressive gynecological cancers with the highest case-fatality rate and it constitutes 90%–95% of all ovarian cancer cases [79]. Although mortality rates have declined by 33% between 1976 and 2015 through improvements in treatment, it is sti...
ImportanceUterus transplant in women with absolute uterine-factor infertility offers the possibility of carrying their own pregnancy. ObjectiveTo determine whether uterus transplant is feasible and safe and results in births of healthy infants. Design, Setting, and ParticipantsA case series including 2...
The treatment of cervical cancer has been protocolled, but the management of uterovaginal prolapse associated with car... Catarina,Pardal,Catia,... - 《Bmj Case Reports》 被引量: 2发表: 2015年 What is the role of hysterectomy in pelvic organ prolapse treatment? Pelvic organ prolapse (POP) ...
d Pathologies associated with the human uterus, such as a medically required surgical removal of the uterus or a lesion of the endometrial wall following cancer treatment, could be targeted with stem cell-based uteri. Patient-derived primary cells could be expanded in vitro, and seeded onto a ...
Uterine cancer is typically diagnosed in its early stages and thus, it is easier to start treatment on time. This is why the 5-year survival rate among women suffering from uterine cancer is quite high, around 90 percent. As the name suggests, uterine cancer begins in the uterus or the ...
Tamoxifen is a non-steroidal triphenylethyl compound which is widely used as adjuvant therapy in the treatment of breast cancer because of its anti-estroge... WG Mccluggage,M Varma,P Weir,... - 《Acta Obstetricia Et Gynecologica Scandinavica》 被引量: 133发表: 1996年 Potential role of LMP...
Uterine Cancer John F. Boggess, Joshua E. Kilgore, in Abeloff's Clinical Oncology (Fifth Edition), 2014 Treatment of Uterine Sarcomas Primary surgery with hysterectomy, with or without oophorectomy, and consideration of cytoreduction is recommended for uterine sarcoma. Surgery on advanced-stage uteri...
Baker.Adjuvant therapy for high‐grade, uterus‐limited leiomyosarcoma[J].Cancer.2013(8)Hensley ML, Wathen JK, Maki RG, Araujo DM, Sutton G, Priebat DA, et al. Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005) Cancer. 2013; 119 (8)...
Uterine sarcomas: natural history, treatment and prognosis. Cancer. 1978;42:1152–60. Article CAS PubMed Google Scholar Salazar OM, Bonfiglio TA, Patten SF, Keller BE, Feldstein ML, Dunne ME, et al. Uterine sarcomas. Analysis of failures with special emphasis on the use of adjuvant ...